Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Fam Pract ; 39(6): 1017-1023, 2022 11 22.
Artigo em Inglês | MEDLINE | ID: mdl-35477768

RESUMO

BACKGROUND: It was verified the level of religiosity and spirituality, and symptoms of depression, stress, and anxiety of caregivers of children and adolescents with type 1 diabetes, and its interference in glycaemic control. METHODS: Socio-economic and demographic data were collected from caregivers of 59 children and adolescents with type 1 diabetes and obtained dosages of fasting glucose (FG); postprandial glycaemia (PPG); fructosamine (FRUTO); and HbA1c, as well as the glycaemic variability-∆HbA1c. Levels of religiosity were obtained by the DUREL scale; the use of religious/spiritual coping was verified by the SRCOPE-Brief scale. Symptoms of depression, anxiety, and stress were analysed by the DASS-21 scale. The correlations between the variables were analysed by the Pearson coefficient, with significance at 5% level. RESULTS: Inverse correlations were observed between caregivers' schooling with PPG (r = -0.30; P = 0.002) and FRUTO (r = -0.34; P = 0.008) and between family income and FRUTO (r = -0.37; P = 0.004). Direct, moderate correlations were observed between negative religious/spiritual coping (NSRCOPE) with symptoms of depression (r = 0.588; P < 0.0001), stress (r = 0.500; P < 0.0001), and anxiety (r = 0.551; P < 0.0001). CONCLUSION: The direct association between NSRCOPE with symptoms of depression, stress, and anxiety was the highlighted item in the present study emphasizing the need for greater attention to the emotional health of informal caregivers of children and adolescents with DM1. It is necessary to reflect on the religious/spiritual support especially for the main caregiver of children and adolescents with DM1.


Assuntos
Cuidadores , Diabetes Mellitus Tipo 1 , Criança , Adolescente , Humanos , Cuidadores/psicologia , Depressão/psicologia , Adaptação Psicológica , Ansiedade/psicologia
2.
Horm Res Paediatr ; 94(11-12): 433-440, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34933304

RESUMO

OBJECTIVE: The aim of this study is to determine the cutoff values of gonadotropin response to gonadotropin-releasing hormone analogs (GnRHas) corresponding to the activation of the hypothalamic-pituitary-gonadal axis that could differentiate central precocious puberty (CPP) from premature thelarche (PT) and using the electrochemiluminescence assay method. METHODS: A total of 49 girls underwent the stimulation test with an intramuscular injection of 3.75 mg leuprolide acetate. Based on the clinical and laboratory characteristics, they were divided into two groups: CPP (n = 22) and PT (n = 27). Baseline estradiol, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) were collected before GnRHa administration and LH and FSH at 60 and 120 min, respectively, after GnRHa administration. RESULTS: The girls with CPP presented an increased height Z-score, advanced bone age, and higher baseline LH, FSH, estradiol, and LH/FSH ratio in relation to PT (p < 0.001). Stimulated LH differed significantly between the two groups, and the LH cutoff values were ≥4.29 IU/L (p < 0.001) and ≥3.95 IU/L at 60 and 120 min, respectively (p < 0.001). The LH peak was found at 60 min after stimulation. CONCLUSIONS: The GnRHa test is effective in distinguishing CPP from PT, and a single sampling, at 60 min, with LH concentrations above 4.29 may be the parameter of choice with the advantage of greater convenience and practicality.


Assuntos
Puberdade Precoce , Feminino , Hormônio Foliculoestimulante , Hormônio Liberador de Gonadotropina , Gonadotropinas , Humanos , Hormônio Luteinizante , Puberdade Precoce/diagnóstico , Puberdade Precoce/tratamento farmacológico
3.
Radiol Bras ; 54(2): 94-98, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33854263

RESUMO

OBJECTIVE: To establish ultrasound reference values for thyroid volumes in children up to 3 years of age, given that ultrasound of the thyroid is an essential examination in the diagnosis of childhood thyroid disease. MATERIALS AND METHODS: This was a prospective study conducted in an iodine-sufficient city in southeastern Brazil. A total of 100 healthy children underwent clinical evaluation, anthropometric examination, and cervical ultrasound in accordance with conventional protocols. We evaluated characteristics such as echotexture, thyroid lobe volume, and total thyroid volume. The children were divided into five groups, by age: < 2 months; 2-12 months; 12-18 months; 18-24 months; and 24-36 months. RESULTS: The mean thyroid volume was lower in the < 2 month age group than in the other groups (0.4 mL vs. 0.18-0.70 mL; p < 0.001). For the subjects between 2 and 36 months of age, the mean volume was 1.0 mL (range, 0.30-2.0 mL). No other significant differences were observed between groups, thyroid lobes, or gender. However, body mass index correlated significantly with total thyroid volume (r = 0.347; p = 0.001). CONCLUSION: The mean thyroid dimensions were smallest in the < 2 month age group (0.35 ± 0.16 mL). For the subjects between 2 and 36 months of age, a reference value of 0.85 ± 0.42 mL can be used. Our data could guide the diagnostic investigation of thyroid disease, especially congenital hypothyroidism, in childhood.


OBJETIVO: Estabelecer valores de referência ultrassonográficos de volumes tireoidianos em crianças de até três anos de idade, por ser exame essencial no diagnóstico de doença tireoidiana infantil. MATERIAIS E MÉTODOS: Trata-se de estudo prospectivo conduzido em cidade do sudeste brasileiro suficiente em iodo. Participaram 100 crianças saudáveis, submetidas a exame clinicoantropométrico e ultrassonografia cervical seguindo protocolos convencionais. Características como ecotextura e volumes dos lobos e da tireoide total foram obtidos. Segundo a idade, as crianças foram distribuídas em cinco grupos: < 2 meses; 2-12 meses; 12-18 meses; 18-24 meses; e 24-36 meses. RESULTADOS: No grupo < 2 meses os volumes tireoidianos foram menores (p < 0,001) do que nos demais (0,4 mL; 0,18-0,70 mL). Além dessa idade, o volume total médio foi 1,0 mL (0,30-2,0 mL) e não diferiu entre os grupos. Não foram observadas diferenças entre lobos ou relacionadas a gênero. Houve correlação (r = 0,347; p = 0,001) entre índice de massa corporal e volume total. CONCLUSÃO: As dimensões tireoidianas foram menores até dois meses (0,35 ± 0,16 mL), e a partir dessa idade os mesmos valores de referência podem ser usados até 36 meses (0,85 ± 0,42 mL). Tais dados podem orientar a investigação diagnóstica, especialmente no hipotireoidismo congênito.

4.
Radiol. bras ; 54(2): 94-98, Jan.-Apr. 2021. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1155235

RESUMO

Abstract Objective: To establish ultrasound reference values for thyroid volumes in children up to 3 years of age, given that ultrasound of the thyroid is an essential examination in the diagnosis of childhood thyroid disease. Materials and Methods: This was a prospective study conducted in an iodine-sufficient city in southeastern Brazil. A total of 100 healthy children underwent clinical evaluation, anthropometric examination, and cervical ultrasound in accordance with conventional protocols. We evaluated characteristics such as echotexture, thyroid lobe volume, and total thyroid volume. The children were divided into five groups, by age: < 2 months; 2-12 months; 12-18 months; 18-24 months; and 24-36 months. Results: The mean thyroid volume was lower in the < 2 month age group than in the other groups (0.4 mL vs. 0.18-0.70 mL; p < 0.001). For the subjects between 2 and 36 months of age, the mean volume was 1.0 mL (range, 0.30-2.0 mL). No other significant differences were observed between groups, thyroid lobes, or gender. However, body mass index correlated significantly with total thyroid volume (r = 0.347; p = 0.001). Conclusion: The mean thyroid dimensions were smallest in the < 2 month age group (0.35 ± 0.16 mL). For the subjects between 2 and 36 months of age, a reference value of 0.85 ± 0.42 mL can be used. Our data could guide the diagnostic investigation of thyroid disease, especially congenital hypothyroidism, in childhood.


Resumo Objetivo: Estabelecer valores de referência ultrassonográficos de volumes tireoidianos em crianças de até três anos de idade, por ser exame essencial no diagnóstico de doença tireoidiana infantil. Materiais e Métodos: Trata-se de estudo prospectivo conduzido em cidade do sudeste brasileiro suficiente em iodo. Participaram 100 crianças saudáveis, submetidas a exame clinicoantropométrico e ultrassonografia cervical seguindo protocolos convencionais. Características como ecotextura e volumes dos lobos e da tireoide total foram obtidos. Segundo a idade, as crianças foram distribuídas em cinco grupos: < 2 meses; 2-12 meses; 12-18 meses; 18-24 meses; e 24-36 meses. Resultados: No grupo < 2 meses os volumes tireoidianos foram menores (p < 0,001) do que nos demais (0,4 mL; 0,18-0,70 mL). Além dessa idade, o volume total médio foi 1,0 mL (0,30-2,0 mL) e não diferiu entre os grupos. Não foram observadas diferenças entre lobos ou relacionadas a gênero. Houve correlação (r = 0,347; p = 0,001) entre índice de massa corporal e volume total. Conclusão: As dimensões tireoidianas foram menores até dois meses (0,35 ± 0,16 mL), e a partir dessa idade os mesmos valores de referência podem ser usados até 36 meses (0,85 ± 0,42 mL). Tais dados podem orientar a investigação diagnóstica, especialmente no hipotireoidismo congênito.

5.
Clinics (Sao Paulo) ; 74: e1205, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31721934

RESUMO

OBJECTIVE: There are no doubts about the clinical benefits of treatment with GnRH analogs for patients diagnosed with central precocious puberty (CPP). However, laboratory monitoring of CPP is still a matter of considerable controversy in the literature. Therefore, the main objective of this study was to evaluate the cut-off values of stimulated LH that determine gonadotrophic suppression. METHODS: Twenty-four girls, on treatment with leuprorelin acetate (LA) at 3.75 mg IM every 28 days, were studied. The clinical parameters used to indicate clinical effectiveness were regression or maintenance of sexual characteristics according to the Tanner stage, growth velocity reduction, reduction or maintenance of the difference between bone age and chronological age and maintenance or improvement of the final height prediction. For the laboratory effectiveness test, basal estradiol, LH, and FSH levels were collected before and 1 and 2 h after the administration of 3.75 mg LA. RESULTS: Eleven girls showed improvement in all clinical parameters, and their effectiveness tests were compared to those of the other patients to calculate the cut-off values, which were ≤3.64 IU/L (p=0.004*) for LH after 1 h and ≤6.10 IU/L (p<0.001*) for LH after 2 h. CONCLUSION: The LH response after the LA stimulation test, associated with clinical data and within a context of CPP, constitutes a reliable and feasible resource and can assist in monitoring the effectiveness of treatment.


Assuntos
Hormônio Foliculoestimulante/sangue , Hormônio Liberador de Gonadotropina/uso terapêutico , Leuprolida/uso terapêutico , Puberdade Precoce/tratamento farmacológico , Estudos de Casos e Controles , Criança , Feminino , Hormônio Liberador de Gonadotropina/análogos & derivados , Humanos , Masculino , Puberdade Precoce/sangue , Resultado do Tratamento
6.
Clinics (Sao Paulo) ; 74: e836, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31241662

RESUMO

OBJECTIVE: Follow-up studies of girls with premature adrenarche have reported the development of polycystic ovary syndrome, insulin resistance, and dyslipidemia and a propensity to cardiovascular disease. The aim of this study was to analyze the presence of these conditions in patients previously treated at the Universidade Federal do Triângulo Mineiro. METHODS: A total of 130 medical records reported premature adrenarche. One hundred and twenty-two patients were invited to participate, of whom 54 accepted; 34 patients were selected, as they had reached their final height. Anthropometric, blood glucose, insulin, and lipid and hormonal profile (LH, FSH, estradiol, 17α-OH-progesterone, androstenedione, dehydroepiandrosterone sulfate, testosterone) data were obtained, the HOMA-IR index was calculated, and pelvic ultrasonography was performed. To characterize polycystic ovary syndrome and metabolic syndrome, the Rotterdam and International Diabetes Federation criteria, respectively, were used. Data were analyzed according to measures of dispersion, frequency and correlations of interest. RESULTS: The age of the participants ranged from 15.2 to 28.2 years/months; 23.5% of the patients were overweight, 11.8% were obese, 29.4% had a large waist circumference, and 8.8% were hypertensive. None of the patients had altered glucose levels, and insulin levels and HOMA-IR were elevated in 29.4% and 38.2% of the participants, respectively; 14.7% of the patients exhibited acanthosis nigricans. The lipid profiles of the participants were variable, and one patient (2.9%) had metabolic syndrome. Polycystic ovary syndrome was found in 41.2% of patients. CONCLUSION: The percentage of patients with polycystic ovary syndrome who also had overweight, obesity and insulin resistance corroborates the literature data about the need for follow-up aiming at interventions, especially for conditions associated with cardiometabolic risk.


Assuntos
Adrenarca/metabolismo , Síndrome do Ovário Policístico/etiologia , Puberdade Precoce/complicações , Puberdade Precoce/metabolismo , Adolescente , Adulto , Índice de Massa Corporal , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/metabolismo , Colesterol/sangue , Dislipidemias/etiologia , Dislipidemias/metabolismo , Feminino , Hormônios/sangue , Humanos , Resistência à Insulina , Síndrome Metabólica/etiologia , Síndrome Metabólica/metabolismo , Sobrepeso/etiologia , Sobrepeso/metabolismo , Síndrome do Ovário Policístico/metabolismo , Valores de Referência , Estudos Retrospectivos , Fatores de Risco , Triglicerídeos/sangue , Adulto Jovem
7.
Clinics ; 74: e1205, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1039542

RESUMO

OBJECTIVE: There are no doubts about the clinical benefits of treatment with GnRH analogs for patients diagnosed with central precocious puberty (CPP). However, laboratory monitoring of CPP is still a matter of considerable controversy in the literature. Therefore, the main objective of this study was to evaluate the cut-off values of stimulated LH that determine gonadotrophic suppression. METHODS: Twenty-four girls, on treatment with leuprorelin acetate (LA) at 3.75 mg IM every 28 days, were studied. The clinical parameters used to indicate clinical effectiveness were regression or maintenance of sexual characteristics according to the Tanner stage, growth velocity reduction, reduction or maintenance of the difference between bone age and chronological age and maintenance or improvement of the final height prediction. For the laboratory effectiveness test, basal estradiol, LH, and FSH levels were collected before and 1 and 2 h after the administration of 3.75 mg LA. RESULTS: Eleven girls showed improvement in all clinical parameters, and their effectiveness tests were compared to those of the other patients to calculate the cut-off values, which were ≤3.64 IU/L (p=0.004*) for LH after 1 h and ≤6.10 IU/L (p<0.001*) for LH after 2 h. CONCLUSION: The LH response after the LA stimulation test, associated with clinical data and within a context of CPP, constitutes a reliable and feasible resource and can assist in monitoring the effectiveness of treatment.


Assuntos
Humanos , Masculino , Feminino , Criança , Puberdade Precoce/tratamento farmacológico , Hormônio Liberador de Gonadotropina/uso terapêutico , Leuprolida/uso terapêutico , Hormônio Foliculoestimulante/sangue , Puberdade Precoce/sangue , Estudos de Casos e Controles , Hormônio Liberador de Gonadotropina/análogos & derivados , Resultado do Tratamento
8.
Clinics ; 74: e836, 2019. tab
Artigo em Inglês | LILACS | ID: biblio-1011915

RESUMO

OBJECTIVE: Follow-up studies of girls with premature adrenarche have reported the development of polycystic ovary syndrome, insulin resistance, and dyslipidemia and a propensity to cardiovascular disease. The aim of this study was to analyze the presence of these conditions in patients previously treated at the Universidade Federal do Triângulo Mineiro. METHODS: A total of 130 medical records reported premature adrenarche. One hundred and twenty-two patients were invited to participate, of whom 54 accepted; 34 patients were selected, as they had reached their final height. Anthropometric, blood glucose, insulin, and lipid and hormonal profile (LH, FSH, estradiol, 17α-OH-progesterone, androstenedione, dehydroepiandrosterone sulfate, testosterone) data were obtained, the HOMA-IR index was calculated, and pelvic ultrasonography was performed. To characterize polycystic ovary syndrome and metabolic syndrome, the Rotterdam and International Diabetes Federation criteria, respectively, were used. Data were analyzed according to measures of dispersion, frequency and correlations of interest. RESULTS: The age of the participants ranged from 15.2 to 28.2 years/months; 23.5% of the patients were overweight, 11.8% were obese, 29.4% had a large waist circumference, and 8.8% were hypertensive. None of the patients had altered glucose levels, and insulin levels and HOMA-IR were elevated in 29.4% and 38.2% of the participants, respectively; 14.7% of the patients exhibited acanthosis nigricans. The lipid profiles of the participants were variable, and one patient (2.9%) had metabolic syndrome. Polycystic ovary syndrome was found in 41.2% of patients. CONCLUSION: The percentage of patients with polycystic ovary syndrome who also had overweight, obesity and insulin resistance corroborates the literature data about the need for follow-up aiming at interventions, especially for conditions associated with cardiometabolic risk.


Assuntos
Humanos , Feminino , Adolescente , Adulto , Adulto Jovem , Síndrome do Ovário Policístico/etiologia , Puberdade Precoce/complicações , Puberdade Precoce/metabolismo , Adrenarca/metabolismo , Valores de Referência , Triglicerídeos/sangue , Resistência à Insulina , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/metabolismo , Índice de Massa Corporal , Colesterol/sangue , Estudos Retrospectivos , Fatores de Risco , Síndrome Metabólica/etiologia , Síndrome Metabólica/metabolismo , Dislipidemias/etiologia , Dislipidemias/metabolismo , Sobrepeso/etiologia , Sobrepeso/metabolismo , Hormônios/sangue
9.
J Complement Integr Med ; 16(2)2018 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-30312163

RESUMO

Background Complementary Spiritist Therapy includes prayer, Spiritist "passe", fluid therapy (fluidic water or magnetized water), and spiritual education, among other therapeutic resources. The objective of this study was to evaluate the effects of Complementary Spiritist Therapy with conventional treatment on emotional status, muscle tension and wellbeing of hospitalized patients with HIV/AIDS. Methods Patients were randomly assigned into either the experimental (3 days [10 mins per day/session] of Complementary Spiritist Therapy alongside conventional treatment; n=20) or control (conventional treatment alone; n=21) group. The primary outcome were positive and negative affects evaluated by the Subjective Wellbeing Scale. The secondary outcome were muscle tension, and wellbeing were assessed by visual analogue scales. Results Significant reductions in negative effects (p=0.045), and muscle tension (p=0.022), along with significant increases in wellbeing (p=0.041) were recorded in the experimental group (Complementary Spiritist Therapy). Conclusions Reductions in negative effects and muscle tension, along with increased perceived wellbeing, were observed in hospitalized patients with HIV/AIDS exposed Complementary Spiritist Therapy combined conventional treatment compared to conventional treatment alone.


Assuntos
Síndrome de Imunodeficiência Adquirida/psicologia , Síndrome de Imunodeficiência Adquirida/terapia , Terapias Complementares , Terapias Espirituais , Síndrome de Imunodeficiência Adquirida/fisiopatologia , Adolescente , Adulto , Emoções , Feminino , Infecções por HIV/psicologia , Infecções por HIV/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Tono Muscular , Resultado do Tratamento , Adulto Jovem
10.
Ciênc. cuid. saúde ; 17(3): e41010, jul. -set. 2018. graf
Artigo em Português | LILACS-Express | LILACS, BDENF - Enfermagem | ID: biblio-1375045

RESUMO

RESUMO O tratamento do Diabetes Mellitus tipo 1 (DM1) constitui-se na adesão ao tratamento insulínico, na alimentação e na atividade física, visando ao controle glicêmico. O objetivo deste estudo foi observar os efeitos da interferência nutricional no tratamento de pacientes com DM1. Trata-se de estudo quantitativo, prospectivo e longitudinal desenvolvido no Ambulatório de Diabetes da UFTM. A coleta de dados foi realizada entre março de 2013 e setembro de 2014. Foram avaliados 41 crianças e adolescentes entre 6 e 17 anos, quanto à antropometria, controle glicêmico e lipídico em 4 momentos: M1 no início do seguimento; M2 após orientação nutricional convencional; M3 após aprendizagem da contagem de carboidratos (CCHO) e M4 em contagem plena. A análise estatística foi descritiva e inferencial. A antropometria comprovou que a CCHO não resultou em ganho de peso e foi efetiva no sexo masculino, demonstrada pela redução nas concentrações de frutosamina (p=0,050) e HbA1C (p=0,041) no M4 comparado ao M1. Considerando a frutosamina, o grupo com CCHO se diferenciou do grupo sem CCHO M4 (p=0,035). A terapêutica insulínica associada à CCHO demonstrou ser um recurso importante a ser integrado no tratamento do DM1, visando atingir alvos efetivos na redução das complicações.


RESUMEN El tratamiento de la Diabetes Mellitus tipo 1 (DM1) se constituye en la adhesión al tratamiento medicamentoso, en la alimentación y en la actividad física, centrando en el control glucémico. El objetivo de este estudio fue observar los efectos de la interferencia nutricional en el tratamiento de pacientes con DM1. Se trata de estudio cuantitativo, prospectivo y longitudinal desarrollado en el Ambulatorio de Diabetes de la UFTM (Universidade Federal do Triângulo Mineiro). La recolección de datos fue realizada entre marzo de 2013 y septiembre de 2014. Fueron evaluados 41 niños y adolescentes entre 6 y 17 años, en cuanto a la antropometría, control glucémico y lipídico en 4 momentos: M1 en el inicio del seguimiento; M2 tras orientación nutricional convencional; M3 tras aprendizaje del conteo de carbohidratos (CCHO) y M4 en conteo pleno. El análisis estadístico fue descriptivo e inferencial. La antropometría comprobó que el CCHO no resultó en ganancia de peso y fue efectivo en el sexo masculino, demostrado por la reducción en las concentraciones de fructosamina (p=0,050) y HbA1C (p=0,041) en el M4 comparado al M1. Considerando la fructosamina, el grupo con CCHO se diferenció del grupo sin CCHO M4 (p=0,035). La terapéutica insulínica asociada al CCHO demostró ser un recurso importante a ser integrado en el tratamiento del DM1, a fin de alcanzar blancos efectivos en la reducción de las complicaciones.


ABSTRACT The treatment of Diabetes Mellitus Type 1 (DM1) involves adherence to insulin treatment, diet and physical activity, aiming at glycemic control. The objective of this study was to observe the effects of nutritional interference in the treatment of patients with DM1. It is a quantitative, prospective and longitudinal study developed at the UFTM Diabetes Outpatient Clinic. Data collection was performed between March 2013 and September 2014. Thirty-one children and adolescents between 6 and 17 years old were evaluated for anthropometry, glycemic and lipid control in four stages: M1 at the beginning of follow-up; M2 after conventional nutritional counseling; M3 after learning the carbohydrate count (CCHO) and M4 in full count. Statistical analysis was descriptive and inferential. The anthropometry showed that CCHO did not result in weight gain and was effective in males, demonstrated by the reduction in the concentrations of fructosamine (p=0.050) and HbA1C (p=0.041) in M4 compared to M1. Considering the fructosamine, the CCHO group differed from the non-CCHO M4 group (p=0.035). CCHO-associated insulin therapy has been shown to be an important resource to be integrated into the treatment of DM1 to achieve effective targets in reducing complications.

11.
Rev. bras. educ. méd ; 42(1): 67-74, jan.-mar. 2018. tab
Artigo em Português | LILACS | ID: biblio-958562

RESUMO

RESUMO Introdução: Alguns autores encontraram relação estreita e positiva da religiosidade e espiritualidade com comportamentos saudáveis, resultando em saúde adequada. Além disso, dados da literatura sugerem que, de modo geral, as pessoas se apoiam em suas crenças para enfrentar momentos de dificuldades pessoais e coletivas. Os profissionais cujas práticas estão ligadas ao cuidado em saúde necessitam se capacitar para atender e respeitar as manifestações e necessidades dos pacientes no que se refere a religiosidade e espiritualidade. Objetivos: Investigar o que pensam os acadêmicos ingressantes no curso de Medicina e de outras áreas da saúde e humanas acerca do tema; identificar o papel e a importância da religiosidade e espiritualidade em suas vidas e futuras práticas profissionais. Metodologia: Trata-se de estudo quantitativo-qualitativo, descritivo, transversal, de amostra intencional. Entre fevereiro e abril de 2014, foi aplicado aos acadêmicos do primeiro período de Medicina, Biomedicina, Enfermagem, Fisioterapia, Terapia Ocupacional, Educação Física, Nutrição, Psicologia e Serviço Social um questionário que avaliou variáveis sociodemográficas e conceitos que envolvem religiosidade e espiritualidade e saúde. A análise dos dados empregou Qui-Quadrado clássico, feita pelo SPSS versão 2.0, e P < 0,05 foi considerado significante. Resultados: Foram selecionados 270 alunos, de 18 a 43 anos; entretanto, 183 preencheram o questionário, sendo a maioria do sexo feminino, de família convencional, cristã/católica, que herdou a religião dos pais; 78,6% (144/183) referiram afiliação religiosa, 43,5% (87/183) a exercem de forma organizacional. A maioria dos indivíduos considerou que a religiosidade e espiritualidade confere sentido a suas vidas, fortalece em momentos difíceis, traz benefícios à saúde, e considera importante a abordagem de temas relacionados em sua formação acadêmica, enquanto 31,4% (57/183) referiram que houve influência da religiosidade e espiritualidade na escolha profissional. Conclusão: Os alunos das áreas estudadas que ingressaram na Universidade Federal do Triângulo Mineiro manifestaram características positivas relacionadas ao tema religiosidade e espiritualidade, e têm expectativa de uma abordagem mais integral e espiritual do homem na grade curricular.


ABSTRACT Introduction: Some authors have found close and positive relationship between religiosity and spirituality and healthy behaviors that result in good health. Furthermore, data drawn from the literature suggest that, in general, people rely on their beliefs to face moments of personal and collective difficulties. Professionals whose practices are linked to health care, need to be trained to meet and observe the needs of patients, in terms of religiosity and spirituality. Objective: To investigate what medical students as well as students in the health area think about this topic, in addition to identifying the role and importance they attribute to religiosity and spirituality in their lives and future professional practices. Methodology: This was a quantitative and qualitative, descriptive, cross intentional sample study. We applied a questionnaire to first-year students of medicine, biomedicine, nursing, physiotherapy, occupational therapy, physical education, nutrition, psychology and social service, which assessed socio-demographic variables and concepts involving religiosity and spirituality and health. For the data analysis, we used the Chi-Square test developed in SPSS version 2.0, and P<0.05 was considered significant. Results: We selected 270 students, aged between 18 and 43, however, only 183 completed the questionnaire. The majority of the respondents were female, who come from conventional Catholic and Christian families, and inherited their religion from their parents; 78.6% (144/183) report religious affiliation, 43.5% (87/183) practice it in a disciplined way. Most the individuals considered that R/S gives meaning to their lives, strengthens them in times of trouble and brings benefits to their health. They also consider religiosity and spirituality and issues related issues as very important to their academic background, whereas 31.4% (57/183) quoted that religiosity and spirituality have influenced their professional choice. Conclusion: Those who have become students at the Universidade Federal do Triângulo Mineiro have a positive attitude towards religiosity and spirituality and expect a more comprhensive and spiritual approach towards their curriculum.

12.
Clinics (Sao Paulo) ; 72(4): 218-223, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28492721

RESUMO

OBJECTIVE:: To evaluate the effectiveness of the treatment of acromegaly patients at the Federal University of Triangulo Mineiro. METHODS:: Cross-sectional and retrospective study of thirty cases treated over a period of two decades. RESULTS:: 17 men (56.7%) aged 14-67 years and 13 women aged 14-86 years were analyzed. Twenty-one patients underwent transphenoidal surgery, whichwas associated with somatostatin receptor ligands in 11 patients (39.3%), somatostatin receptor ligands + radiotherapyin 5 patients (17.8%), radiotherapy in 3 patients (10.7%), and radiotherapy + somatostatin receptorligands + cabergoline in 1 patient (3.6%). Additionally, 2 patients underwent radiotherapy and surgeryalone. Six patients received somatostatin receptor ligands before surgery, and 2 were not treated due to refusal and death. Nine patients have died, and 20 are being followed; 13 (65%) have growth hormonelevels o1 ng/mL, and 11 have normal insulin-like growth factor 1 levels. CONCLUSION:: The current treatment options enable patients seen in regional reference centers to achieve strict control parameters, which allows them to be treated close to their homes.


Assuntos
Acromegalia/terapia , Adenoma/cirurgia , Adenoma Hipofisário Secretor de Hormônio do Crescimento/cirurgia , Receptores de Somatostatina/metabolismo , Acromegalia/sangue , Adenoma/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Glicemia/análise , Brasil , Terapia Combinada , Estudos Transversais , Feminino , Gigantismo/sangue , Gigantismo/terapia , Hormônio do Crescimento/sangue , Humanos , Fator de Crescimento Insulin-Like I/análise , Ligantes , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
13.
Clinics ; 72(4): 218-223, Apr. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-840068

RESUMO

OBJECTIVE: To evaluate the effectiveness of the treatment of acromegaly patients at the Federal University of Triangulo Mineiro. METHODS: Cross-sectional and retrospective study of thirty cases treated over a period of two decades. RESULTS: 17 men (56.7%) aged 14-67 years and 13 women aged 14-86 years were analyzed. Twenty-one patients underwent transphenoidal surgery, whichwas associated with somatostatin receptor ligands in 11 patients (39.3%), somatostatin receptor ligands + radiotherapyin 5 patients (17.8%), radiotherapy in 3 patients (10.7%), and radiotherapy + somatostatin receptorligands + cabergoline in 1 patient (3.6%). Additionally, 2 patients underwent radiotherapy and surgeryalone. Six patients received somatostatin receptor ligands before surgery, and 2 were not treated due to refusal and death. Nine patients have died, and 20 are being followed; 13 (65%) have growth hormonelevels o1 ng/mL, and 11 have normal insulin-like growth factor 1 levels. CONCLUSION: The current treatment options enable patients seen in regional reference centers to achieve strict control parameters, which allows them to be treated close to their homes.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Acromegalia/terapia , Adenoma/cirurgia , Adenoma Hipofisário Secretor de Hormônio do Crescimento/cirurgia , Receptores de Somatostatina/metabolismo , Acromegalia/sangue , Adenoma/metabolismo , Glicemia/análise , Brasil , Terapia Combinada , Estudos Transversais , Gigantismo/sangue , Gigantismo/terapia , Hormônio do Crescimento/sangue , Fator de Crescimento Insulin-Like I/análise , Ligantes , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...